Instrument Inactif

Communiqués Taro Pharmaceutical Industries Ltd. Other OTC

Actions

IL0010827181

Produits pharmaceutiques

Cours en clôture Other OTC Autres places de cotation
- ^USD	-

01/07	La FDA accorde une approbation provisoire pour l'ANDA 212581 concernant la mousse topique d'acide azélaïque	CI
24/06/24	Sun Pharmaceutical Industries Limited (NSEI:SUNPHARMA) a acquis la participation restante de 21,5 % dans Taro Pharmaceutical Industries Ltd. (NYSE:TARO) auprès de Krensavage Asset Management, LLC et d'autres parties pour un montant d'environ 1,5 million d'euros.	CI

Communiqués

24/06/24	Taro Pharmaceutical Industries : Sun Pharma Completes Taro Merger Form 6 K	PU
23/05/24	Taro Shareholders Approve Merger with Sun Pharma	PR
23/05/24	Taro Pharmaceutical Industries : Shareholders Approve Merger with Sun Pharma - Form 6-K	PU
21/05/24	Taro Pharmaceutical Industries : PROVIDES RESULTS FOR YEAR ENDED MARCH 31, 2024 - Form 6-K	PU
20/05/24	Taro: Fiscal Q4 Earnings Snapshot	AQ
20/05/24	Taro Provides Results for Year Ended March 31, 2024	BU
15/05/24	Taro to Release Full Year Results on May 20, 2024	BU
09/05/24	Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote 'FOR' Taro Sun Pharma Merger	AQ
08/05/24	Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote “FOR” Taro Sun Pharma Merger	BU
22/04/24	TARO PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Taro Pharmaceutical Industries Ltd. - TARO	BU
15/04/24	Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.	BU
07/02/24	TARO PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Taro Pharmaceutical Industries Ltd. - TARO	BU
30/01/24	Kuehn Law Encourages PGTI, TAST, TARO, and ANSS Investors to Contact Law Firm	PR
30/01/24	Krensavage Asset Management Remains Opposed to Sun's Predatory Bid for Taro	PR
25/01/24	Taro: Fiscal Q3 Earnings Snapshot	AQ
25/01/24	Taro Provides Results for December 31, 2023	BU
19/01/24	Taro to Release Third Quarter Results on January 25, 2024	BU
17/01/24	Taro Announces Merger Agreement with Sun Pharma	PR
11/12/23	Taro Pharmaceutical Industries : Potential Transaction with Controlling Shareholder - Form 6-K	PU
26/10/23	Taro: Fiscal Q2 Earnings Snapshot	AQ
26/10/23	Taro Provides Results for September 30, 2023	BU
19/10/23	Taro to Release Second Quarter Results on October 26, 2023	BU
27/07/23	Taro: Fiscal Q1 Earnings Snapshot	AQ
27/07/23	Taro Provides Results for the Quarter Ended June 30, 2023	BU
27/07/23	Taro Pharmaceutical Industries : Provides Results for the Quarter Ended June 30, 2023	PU